Literature DB >> 19557742

Sodium time course using 23Na MRI in reversible focal brain ischemia in the monkey.

George C LaVerde1, Charles A Jungreis, Edwin Nemoto, Fernando E Boada.   

Abstract

PURPOSE: To demonstrate the use of sodium MRI for measuring the time course of tissue sodium concentration (TSC) in a nonhuman primate model of reversible focal brain ischemia.
MATERIALS AND METHODS: Reversible endovascular focal brain ischemia was induced in nonhuman primates (n = 4), and sodium MRI was performed on a 3 Tesla scanner for monitoring changes in TSC during both the middle cerebral artery (MCA) occlusion and MCA reperfusion portions of the experiment.
RESULTS: The TSC increased linearly in the ischemic tissue during MCA occlusion (ranging from a mean TSC increase of 5.44%/h to 7.15%/h across the four subjects), and then there was a statistically significant change from a positive TSC slope during MCA occlusion to a TSC slope after MCA reperfusion that was not statistically different from zero. The linear increase in sodium MRI during brain ischemia was used to estimate the stroke onset time to within 0.45 h in each of the four subjects (with a maximum 95% confidence interval of +/- 1.147 h).
CONCLUSION: The data indicate that sodium MRI increases linearly during brain ischemia, and that this increase is stopped by tissue reperfusion within 5.4 h after stroke onset. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557742     DOI: 10.1002/jmri.21723

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

1.  High-resolution sodium imaging of human brain at 7 T.

Authors:  Yongxian Qian; Tiejun Zhao; Hai Zheng; Jonathan Weimer; Fernando E Boada
Journal:  Magn Reson Med       Date:  2011-12-05       Impact factor: 4.668

2.  Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment.

Authors:  Xuegang Yuan; Jens T Rosenberg; Yijun Liu; Samuel C Grant; Teng Ma
Journal:  Cytotherapy       Date:  2019-09-17       Impact factor: 5.414

3.  Intravenous HOE-642 reduces brain edema and Na uptake in the rat permanent middle cerebral artery occlusion model of stroke: evidence for participation of the blood-brain barrier Na/H exchanger.

Authors:  Martha E O'Donnell; Yi-Je Chen; Tina I Lam; Kelleen C Taylor; Jeffrey H Walton; Steven E Anderson
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

4.  Sodium-23 magnetic resonance imaging has potential for improving penumbra detection but not for estimating stroke onset time.

Authors:  Friedrich Wetterling; Lindsay Gallagher; Jim Mullin; William M Holmes; Chris McCabe; I Mhairi Macrae; Andrew J Fagan
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-22       Impact factor: 6.200

5.  Sodium MRI and the assessment of irreversible tissue damage during hyper-acute stroke.

Authors:  Fernando E Boada; Yongxian Qian; Edwin Nemoto; Tudor Jovin; Charles Jungreis; S C Jones; Jonathan Weimer; Vincent Lee
Journal:  Transl Stroke Res       Date:  2012-05-04       Impact factor: 6.829

6.  Multimodal MRI of nonhuman primate stroke.

Authors:  Hsiao-Ying Wey; Timothy Q Duong
Journal:  Transl Stroke Res       Date:  2012-02-04       Impact factor: 6.829

7.  Endovascular Ischemic Stroke Models in Nonhuman Primates.

Authors:  Di Wu; Ankush Chandra; Jian Chen; Yuchuan Ding; Xunming Ji
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

8.  Imaging Stroke Evolution after Middle Cerebral Artery Occlusion in Non-human Primates.

Authors:  H E D'Arceuil; Alex J de Crespigny
Journal:  Open Neuroimag J       Date:  2011-11-18

9.  Investigating potentially salvageable penumbra tissue in an in vivo model of transient ischemic stroke using sodium, diffusion, and perfusion magnetic resonance imaging.

Authors:  Friedrich Wetterling; Eva Chatzikonstantinou; Laurent Tritschler; Stephen Meairs; Marc Fatar; Lothar R Schad; Saema Ansar
Journal:  BMC Neurosci       Date:  2016-12-07       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.